Diagnostics
Raimond takes helm at Nuclera
October 26, 2026Biotechnology, Diagnostics, appointments
Nuclera, the biotechnology company enabling access to innovative protein technologies, has appointed Carl Raimond as Chief Executive Officer, effective immediately. …
Jennings becomes President of Beckman Coulter Diagnostics
October 19, 2026Beckman Coulter Diagnostics, Corporate, Diagnostics, appointments
Beckman Coulter Diagnostics has appointed Catherine Jennings as its new President. In this role, Jennings will lead the company’s strategic, …
Boyds expands Regulatory Affairs team to support growing demand
October 16, 2026Consultancy, Diagnostics, Pharmacy, drug development, life sciences, regulatory affairs
Vicki Hayes has joined Boyds as Vice President of Regulatory Affairs with Jan Ohotski becoming Director of Regulatory Affairs. Hayes …
Femtosecond laser cuts lung tumour margin assessment time
October 15, 2026Devices, Diagnostics, Hospital Management, Oncology, laser imaging, lung disease, tumour
Femtosecond laser imaging has reduced the time needed to assess lung tumour margins from 36 minutes to less than six …
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
October 15, 2026Diagnostics, Haematology, Neurological Diseases, Neurology, Parkinson's disease, blood testing, sleep disorder
Researchers at King Abdullah University of Science and Technology (KAUST) and the University of Oxford have developed a blood-based electronic …
Trio become latest Symbiosis commercial additions
October 12, 2026CDMO, Devices, Diagnostics, Immunology, clinical trials, pharmaceutical markets
Symbiosis Pharmaceutical Services has further strengthened its commercial team with three new appointments. Payal Roychoudhury and JoaquÃn Pérez Fornieles join …
How will biomarker-led diagnostics reshape respiratory medicine?
October 11, 2026Asthma & COPD, COPD, Chronic Diseases, Diagnostics, biomarkers, clinical trial
By Dr Louise Ryan Murphy, Chronic obstructive pulmonary disease (COPD) is typically diagnosed and assessed through symptoms, lung function and …
“That gap between innovation and delivery was what stood out to me most”
October 11, 2026Drug Delivery Systems, Drug Safety, Marketing, Medical Communications, Regulatory Affairs AI governance, Asthma & COPD, Chronic Diseases, Devices, Diagnostics, Hospital Management, NHS, drug delivery, healthcare solutions, pharmaceutical technology
Pharmafile chats with Camunda’s Natosha McNeal about the vital role of delivery, onboarding AI and putting the patient at the …
Agentic commercial: how AI creates dialogue with HCPs and patients to help medicines reach them faster
October 11, 2026Licenses/Quality Standards, Marketing, Sales & Marketing Training AI, Devices, Diagnostics, Hospital Management, Pharmacy, biopharma, medical adoption, pharmaceutical
By Chris Moore Commercial engagement in biopharma used to centre largely on direct conversations between sales reps and physicians or …
Product value to pathway impact: What the CVD Modern Service Framework means for pharma
August 9, 2026Cardiology, Cardiovascular Health, Diagnostics, Hospital Management, Modern Service Framework, NHS
By Sabina Syed and Ewan Maule The Cardiovascular Disease Modern Service Framework1(CVD MSF) begins with a familiar problem at a much …
Functional lung imaging offers new possibilities for respiratory care
August 9, 2026Data Capture Asthma & COPD, Computed tomography, Diagnostics, digital technologies, medical imaging
Advances in computed tomography (CT) technology are helping to reshape the diagnosis and management of chronic respiratory disease, with new …
KIFFIK Biomedical expands leadership team with two executive appointments
August 14, 2025Research and Development Chief Investment Officer, Corporate, Diagnostics, KIFFIK Biomedical, chief scientific officer
KIFFIK Biomedical has strengthened its leadership team with the appointments of Rene Veloso as chief investment officer and Reginald Swift …
Inbiome’s rapid diagnostic platform approved for EU use, cuts infection identification time to just five hours
April 11, 2025Research and Development Diagnostics, EU, Inbiome
Dutch diagnostics firm Inbiome has received In Vitro Diagnostic Regulation (IVDR) certification from the EU for its Molecular Culture ID …
CANDOR Bioscience acquired by Medix Biochemica
January 31, 2025Sales and Marketing CANDOR biosciences, Diagnostics, Medix biochemica, acquisition, in vitro diagnostics
CANDOR Biosciences, a supplier in immunoassay solutions, has been acquired by Medix Biochemica, a supplier of raw materials for in …
Verisense announce opening of Digital Biobank
August 14, 2024Research and Development AI, Devices, Diagnostics, Verisense, artificial intelligence, digital health, machine learning
This week, Verisense have announced that their Digital Biobank, with data from over one million people, is open for business.
Latest content
Dermatology leader Doncker is new Onicor CEO
